Therapeutics Advances
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Jan 25, 2016; 8(2): 40-55
Published online Jan 25, 2016. doi: 10.4253/wjge.v8.i2.40
Table 3 Colorectal endoscopic submucosal dissection outcomes for epithelial neoplasms in European studies
Ref.Patients, n (% rectal)Study designEnrollment periodSize (mm)Time (min)En bloc (%)R0 (%)Perforation rate (%)Delayed bleeding (%)Hospital stay (d)Follow-up
Farhat et al[16], 201185 (84.7)ProspectiveJan 2008 Aug 2010--6762.3----
Probst et al[14], 201276 (86.6)NSOct 2004 Sep 201145.817681.669.76.610.5-Median: 23.6 mo (2-83) Included in follow-up: n = 65 9.2% residual neoplasms (5 piecemeal and 1 en bloc R1 lateral)
Repici et al[20], 201340 (100)ProspectiveApr 2010 Jan 201146.886.1908052.5-Recurrences: 2.5%
Thorlacius et al[126], 201329 (59)NSJan 2012 Mar 20132814272696.90-Recurrences: 0% at 3-6 mo Missing rate: 82.7%
Spychalski et al[127], 201570 (56)NSJun 2013 Jun 20143011066-86-Missing rate: 14.6% Recurrences: 4.9% Follow-up < 12 mo
Rahmi et al[128], 201445 (100)NSFeb 2010 Jun 201235110645318133.4For curative resections at 12 mo: 88%
Bialek et al[129], 201437 (67.6)Prospective2007 2013377086.581.105.7-At 1-yr follow-up: 1.7% recurrences